The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future.
Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.
The ABPI and its members contributed actively to the development of the 2015 Matrix Report on Life Sciences, the 2016 NI Life Sciences Strategic Implementation Plan and the 2019 formation of the Health Innovation Research Alliance Northern Ireland (HIRANI).
The ABPI is committed to supporting Northern Ireland to become a thriving health and life ecosystem to the benefit of patients, Health and Social Care and the economy.
MOIC was set up by the Department of Health to create a medicines optimisation model for NI, with quality standards and an innovation and change programme.
MOIC work can be encapsulated under four main thematic headings namely focusing on the needs of the Northern Ireland population, accelerate the adoption of innovation into practice to improve clinical outcomes and patient experience, build a culture of partnership and collaboration, and make a meaningful contribution to the Northern Ireland economy.
In relation to these key themes, MOIC sees ABPI as a key partner in delivering on these objectives and the formalising of the current good working relationship is a further positive development bringing enhanced benefits.